Wealth Enhancement Advisory Services, LLC Rapt Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,020 shares of RAPT stock, worth $8,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,020Holding current value
$8,595% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
101Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$17.4 Million7.04% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$10.2 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$10.2 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$9.75 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$9.18 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $23.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...